Predicted Trait | |
Reported Trait | Endometrial cancer |
Mapped Trait(s) | endometrial carcinoma (EFO_1001512) |
Score Construction | |
PGS Name | PRS16_endometrium |
Development Method | |
Name | PRSice-2 |
Parameters | p = 5E-8, r2 = 0.1 |
Variants | |
Original Genome Build | NR |
Number of Variants | 16 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000542 |
Citation (link to publication) | Kim ES et al. NPJ Precis Oncol (2023) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 121,885 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006464 Europe PMC: 30093612 |
121,885 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM020301 | PSS011328| European Ancestry| 133,830 individuals |
PGP000542 | Kim ES et al. NPJ Precis Oncol (2023) |
Reported Trait: Endometrial cancer | HR: 1.25 [1.14, 1.36] | — | — | first 10 genetic principal components | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011328 | — | — | 133,830 individuals, 0.0 % Male samples |
— | European (British) |
— | UKB | — |